Delivering next-generation treatments for back of the eye disorders, with focus on diabetic eye disease


ThromboGenics, Inc., Iselin, New Jersey (US)

ThromboGenics, Inc. launched JETREA® (ocriplasmin) in the US on January 14, 2013.

Today, the US branch has grown into a mature commercial organization, supported by a wide distribution network and an energetic administrative staff.


101 Wood Avenue South
Suite 610
Iselin, NJ 08830 USA

T +1 732 590 2900
T +1 855 301 1600